Global emerging resistance in pediatric infections with TB, HIV, and gram-negative pathogens

References

• World Health Organization. Antimicrobial resistance. [Accessed April 7, 2020] Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
   Google Scholar
• World Health Organization. Global action plan on antimicrobial resistance. Geneva: WHO; 2015.
   Google Scholar
• World Health Organization. Global Tuberculosis Report 2019. Geneva: WHO; 2019.
   Google Scholar
• Ford N, Matteelli A, Shubber Z, et al. TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis. J Int AIDS Soc. 2016;19:20714.
   Google Scholar
• Marais BJ, Schaaf HS. Childhood tuberculosis: an emerging and previously neglected problem. Infect Dis Clin North Am. 2010;24:727–749.
   Google Scholar
• Nahid P, Mase SR, Migliori GB, et al. Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline. Am J Respir Crit Care Med. 2019;200:e93–e142.
   Google Scholar
• Dodd PJ, Gardiner E, Coghlan R, et al. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014;2:e453–e459.
   Google Scholar
• Dodd PJ, Yuen CM, Sismanidis C, et al. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health. 2017;5:e898–e906.
   Google Scholar
• World Health Organization. Consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: WHO; 2019.
   Google Scholar
• Dodd PJ, Sismanidis C, Seddon JA. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. Lancet Infect Dis. 2016;16:1193–1201.
   Google Scholar
• Dheda K, Gumbo T, Maartens G, et al. The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis. Lancet Respir Med. 2019;7:820–826.
   Google Scholar
• Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:111–115.
   Google Scholar
• Starke JR. Interferon-gamma release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics. 2014;134:e1763–1773.
   Google Scholar
• Nahid P, Dorman SE, Alipanah N, et al. Executive summary: official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:853–867.
   Google Scholar
• Furin J, Isaakidis P, Reid AJ, et al. ‘I’m fed up’: experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV. Int J Tuberc Lung Dis. 2014;18:1479–1484.
   Google Scholar
• Furin J, Loveday M, Hlangu S, et al. “A very humiliating illness”: a qualitative study of patient-centered care for rifampicin-resistant tuberculosis in South Africa. BMC Public Health. 2020;20:76.
   Google Scholar
• Isaakidis P, Rangan S, Pradhan A, et al. ‘I cry every day’: experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Trop Med Int Health. 2013;18:1128–1133.
   Google Scholar
• UNAIDS. UNAIDS estimates. 2019. [Accessed March 29, 2020] Available from: https://aidsinfo.unaids.org
   Google Scholar
• World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. September 2015.
   Google Scholar
• Ford N, Penazzato M, Vitoria M, et al. The contribution of observational studies in supporting the WHO ‘treat all’ recommendation for HIV/AIDS. J Virus Erad. 2018;4:5–8.
   Google Scholar
• UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. 2014. p. 1–40.
   Google Scholar
• UNAIDS. Ending AIDS: progress towards the 90- 90-90targets. [Accessed March 29, 2020] Available from: http://www.unaids.org/en/resources/documents/2017/20170720_Global_AIDS_update_2017
   Google Scholar
• Yotebieng M, Brazier E, Addison D, et al. Research priorities to inform “treat all” policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc. 2019;22:e25218.
   Google Scholar
• Davies M-A, Pinto J. Targeting 90–90–90 – don’t leave children and adolescents behind. J Int AIDS Soc. 2015;18:1–6.
   Google Scholar
• Enane LA, Davies MA, Leroy V, et al. Traversing the cascade: urgent research priorities for implementing the ‘treat all’ strategy for children and adolescents living with HIV in sub-Saharan Africa. J Virus Erad. 2018;4:40–46.
   Google Scholar
• Enane LA, Vreeman RC, Foster C. Retention and adherence: global challenges for the long-term care of adolescents and young adults living with HIV. Curr Opin HIV AIDS. 2018;13:212–219.
   Google Scholar
• Wood SM, Dowshen N, Lowenthal E. Time to improve the global human immunodeficiency virus/AIDS care continuum for adolescents: a generation at stake. JAMA Pediatr. 2015;169:619–620.
   Google Scholar
• World Health Organization. HIV drug resistance report. Geneva: WHO; 2019.
   Google Scholar
• World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diangosis of HIV. Geneva: WHO; 2018.
   Google Scholar
• Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV. Guidelines for the use of antiretroviral agents in pediatric HIV infection. [Accessed March 29, 2020] Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/pediatricguidelines.pdf
   Google Scholar
• Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med. 2018;379:979–981.
   Google Scholar
• Zash R, Holmes L, Diseko M, et al. Neural-tube defects and antiretroviral treatment regimens in Botswana. N Engl J Med. 2019;381:827–840.
   Google Scholar
• World Health Organization. Update of recommendations on first- and second-line antiretroviral regimens. [Accessed March 29, 2020] Available from: https://www.who.int/hiv/pub/arv/arv-update-2019-policy/en/
   Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. [Accessed March 31, 2020] Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf
   Google Scholar
• Ruel T, Acosta E, Singh R, et al. Pharmacokinetic and 4-week safety/efficacy of dolutegravir (S/GSK1349572) dispersible tablets in HIV-infected children aged 4 weeks to <6 years: results from IMPAACT P1093. International AIDS Conference; 2018; Amsterdam, Netherlands. Available from: https://www.natap.org/2018/IAC/IAC_44.htm
   Google Scholar
• Vreeman RC, Wiehe SE, Pearce EC, et al. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008;27:686–691.
   Google Scholar
• Simoni JM, Montgomery A, Martin E, et al. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007;119:e1371–e1383.
   Google Scholar
• Enane LA, Mokete K, Joel D, et al. “We did not know what was wrong”– barriers along the care cascade among hospitalized adolescents with HIV in Gaborone, Botswana. PLoS One. 2018;13:e0195372.
   Google Scholar
• Dow DE, Turner EL, Shayo AM, et al. Evaluating mental health difficulties and associated outcomes among HIV-positive adolescents in Tanzania. AIDS Care. 2016;28:825–833.
   Google Scholar
• Judd A, Sohn AH, Collins IJ. Interventions to improve treatment, retention and survival outcomes for adolescents with perinatal HIV-1 transitioning to adult care. Curr Opin HIV AIDS. 2016;11:477–486.
   Google Scholar
• Izzo I, Quiros-Roldan E, Saccani B, et al. Perinatally HIV-infected youths after transition from pediatric to adult care, a single-center experience from Northern Italy. AIDS Res Hum Retroviruses. 2018;34:241–243.
   Google Scholar
• Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Aids. 2009;51:65–71.
   Google Scholar
• MacPherson P, Munthali C, Ferguson J, et al. Service delivery interventions to improve adolescents’ linkage, retention and adherence to antiretroviral therapy and HIV care. Trop Med Int Health. 2015;20:1015–1032.
   Google Scholar
• Kariminia A, Law M, Davies MA, et al. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration. J Int AIDS Soc. 2018;21:e25215.
   Google Scholar
• Desmonde S, Tanser F, Vreeman R, et al. Access to antiretroviral therapy in HIV-infected children aged 0–19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004–2015: a prospective cohort study. PLoS Med. 2018;15:e1002565.
   Google Scholar
• Braitstein P, Songok J, Vreeman RC, et al. “Wamepotea” (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya. J Aids. 2011;57:e40–e46.
   Google Scholar
• Enane LA, Apondi E, Toromo J, et al. “A problem shared is half solved” – a qualitative assessment of barriers and facilitators to adolescent retention in HIV care in western Kenya. AIDS Care. 2020;32:104–112.
   Google Scholar
• Machine EM, Gillespie SL, Homedes N, et al. Lost to follow-up: failure to engage children in care in the first three months of diagnosis. AIDS Care. 2016;28:1–9.
   Google Scholar
• Cluver LD, Hodes RJ, Sherr L, et al. Social protection: potential for improving HIV outcomes among adolescents. J Aids. 2015;18:1–7.
   Google Scholar
• Murray KR, Dulli LS, Ridgeway K, et al. Improving retention in HIV care among adolescents and adults in low- and middle-income countries: a systematic review of the literature. PLoS One. 2017;12:e0184879–e0184822.
   Google Scholar
• Nyaku AN, Kelly SG, Taiwo BO. Long-acting antiretrovirals: where are we now? Curr HIV/AIDS Rep. 2017;14:63–71.
   Google Scholar
• Simoni JM, Beima-Sofie K, Mohamed ZH, et al. Long-acting injectable antiretroviral treatment acceptability and preferences: a qualitative study among US providers, adults living with HIV, and parents of youth living with HIV. AIDS Patient Care STDS. 2019;33:104–111.
   Google Scholar
• Castor D, Meyers K, Allen S. The only way is up: priorities for implementing long-acting antiretrovirals for HIV prevention and treatment. Curr Opin HIV AIDS. 2020;15:73–80.
   Google Scholar
• Weld ED, Rana MS, Dallas RH, et al. Interest of youth living with HIV in long-acting antiretrovirals. J Acquir Immune Defic Syndr. 2019;80:190–197.
   Google Scholar
• Bekker LG, Tatoud R, Dabis F, et al. The complex challenges of HIV vaccine development require renewed and expanded global commitment. Lancet. 2020;395:384–388.
   Google Scholar
• Pitman MC, Lau JSY, McMahon JH, et al. Barriers and strategies to achieve a cure for HIV. Lancet HIV. 2018;5:e317–e328.
   Google Scholar
• Byington CL, Rittichier KK, Bassett KE, et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics. 2003;111:964–968.
   Google Scholar
• Hoberman A, Greenfield SP, et al.; RIVUR Trial Investigators. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370:2367–2376.
   Google Scholar
• Baig MT, Sial AA, Huma A, et al. Irrational antibiotic prescribing practice among children in critical care of tertiary hospitals. Pak J Pharm Sci. 2017;30:1483–1489.
   Google Scholar
• Tribble AC, Lee BR, Flett KB, et al. Appropriateness of antibiotic prescribing in U.S. children’s hospitals: a national point prevalence survey. Clin Infect Dis. 2020;71:e226–e234.
   Google Scholar
• Miyazaki A, Tung R, Taing B, et al. Frequent unregulated use of antibiotics in rural Cambodian infants. Trans R Soc Trop Med Hyg. 2020;114:401–407.
   Google Scholar
• Allwell-Brown G, Hussain-Alkhateeb L, Kitutu FE, et al. Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005–17: a systematic analysis of 132 national surveys from 73 countries. Lancet Glob Health. 2020;8:e799–e807.
   Google Scholar
• Jernigan JA, Hatfield KM, Wolford H, et al. Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012–2017. N Engl J Med. 2020;382:1309–1319.
   Google Scholar
• Oli AN, Ogbuagu VI, Ejikeugwu CP, et al. Multi-antibiotic resistance and factors affecting carriage of extended spectrum beta-lactamase-producing enterobacteriaceae in pediatric population of Enugu Metropolis, Nigeria. Med Sci (Basel). 2019;7:104.
   Google Scholar
• Molton JS, Tambyah PA, Ang BS, et al. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis. 2013;56:1310–1318.
   Google Scholar
• Francois Watkins LK, Winstead A, Appiah GD, et al. Update on extensively drug-resistant salmonella serotype typhi infections among travelers to or from Pakistan and report of ceftriaxone-resistant salmonella serotype typhi infections among travelers to Iraq – united States, 2018–2019. MMWR Morb Mortal Wkly Rep. 2020;69:618–622.
   Google Scholar
• Chatham-Stephens K, Medalla F, Hughes M, et al. Emergence of extensively drug-resistant Salmonella typhi infections among travelers to or from Pakistan – United States, 2016–2018. MMWR Morb Mortal Wkly Rep. 2019;68:11–13.
   Google Scholar
• Tack B, Phoba MF, Barbe B, et al. Non-typhoidal Salmonella bloodstream infections in Kisantu, DR Congo: emergence of O5-negative Salmonella typhimurium and extensive drug resistance. PLoS Negl Trop Dis. 2020;14:e0008121.
   Google Scholar
• Droz N, Hsia Y, Ellis S, et al. Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2019;8:207.
   Google Scholar
• Chiotos K, Hayes M, Gerber JS, et al. Treatment of carbapenem-resistant enterobacteriaceae infections in children. J Pediatric Infect Dis Soc. 2020;9:56–66.
   Google Scholar
• Aguilera-Alonso D, Escosa-Garcia L, Saavedra-Lozano J, et al. Carbapenem-resistant gram-negative bacterial infections in children. Antimicrob Agents Chemother. 2020;64:e02183–19.
   Google Scholar
• Patil S, Chen H, Zhang X, et al. Antimicrobial resistance and resistance determinant insights into multi-drug resistant gram-negative bacteria isolates from paediatric patients in China. Infect Drug Resist. 2019;12:3625–3634.
   Google Scholar
• Zhu M, Jin Y, Duan Y, et al. Multi-drug resistant Escherichia coli causing early-onset neonatal sepsis – a single center experience from China. Infect Drug Resist. 2019;12:3695–3702.
   Google Scholar
• Motbainor H, Bereded F, Mulu W. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study. BMC Infect Dis. 2020;20:92.
   Google Scholar
• Kayastha K, Dhungel B, Karki S, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in pediatric patients visiting International Friendship Children’s Hospital, Kathmandu, Nepal. Infect Dis (Auckl). 2020;13:1178633720909798.
   Google Scholar
• Kantele A, Laaveri T, Mero S, et al. Despite predominance of uropathogenic/extraintestinal pathotypes among travel-acquired wxtended-spectrum beta-lactamase-producing Escherichia coli, the most commonly associated clinical manifestation is travelers’ diarrhea. Clin Infect Dis. 2020;70:210–218.
   Google Scholar
• Kantele A, Laaveri T, Mero S, et al. Antimicrobials increase travelers’ risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015;60:837–846.
   Google Scholar
• Nellums LB, Thompson H, Holmes A, et al. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18:796–811.
   Google Scholar
• Mekonnen GK, Mengistie B, Sahilu G, et al. Etiologies of diarrhea and drug susceptibility patterns of bacterial isolates among under-five year children in refugee camps in Gambella Region, Ethiopia: a case control study. BMC Infect Dis. 2019;19:1008.
   Google Scholar
• Nadimpalli M, Delarocque-Astagneau E, Love DC, et al. Combating global antibiotic resistance: emerging One Health concerns in lower- and middle-income countries. Clin Infect Dis. 2018;66:963–969.
   Google Scholar
• Hedman HD, Eisenberg JNS, Trueba G, et al. Impacts of small-scale chicken farming activity on antimicrobial-resistant Escherichia coli carriage in backyard chickens and children in rural Ecuador. One Health. 2019;8:100112.
   Google Scholar
• Lemmen SW, Lewalter K. Antibiotic stewardship and horizontal infection control are more effective than screening, isolation and eradication. Infection. 2018;46:581–590.
   Google Scholar
• Messina NL, Williamson DA, Robins-Browne R, et al. Risk factors for carriage of antibiotic-resistant bacteria in healthy children in the community: a systematic review. Pediatr Infect Dis J. 2020;39:397–405.
   Google Scholar
• Lewnard JA, Lo NC, Arinaminpathy N, et al. Childhood vaccines and antibiotic use in low- and middle-income countries. Nature. 2020;581:94–99.
   Google Scholar
• Shakya M, Colin-Jones R, Theiss-Nyland K, et al. Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal. N Engl J Med. 2019;381:2209–2218.
   Google Scholar
• Lin FY, Ho VA, Khiem HB, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med. 2001;344:1263–1269.
   Google Scholar
• Hawser S, Hoban DJ, Badal RE, et al. Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010–2011. J Chemother. 2015;27:67–73.
   Google Scholar
• Keenan JD, Arzika AM, Maliki R, et al. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial. Lancet Glob Health. 2020;8:e288–e295.
   Google Scholar
• Keenan JD, Arzika AM, Maliki R, et al. Longer-term assessment of azithromycin for reducing childhood mortality in Africa. N Engl J Med. 2019;380:2207–2214.
   Google Scholar
• Isanaka S, Langendorf C, Berthe F, et al. Routine amoxicillin for uncomplicated severe acute malnutrition in children. N Engl J Med. 2016;374:444–453.
   Google Scholar